Amaury Herbet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Generating CAR-macrophages to target endothelin B receptor-positive tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: July 11, 2025
Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy.
Journal: BJC reports
Published: July 04, 2024
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Journal: Experimental hematology & oncology
Published: March 12, 2024
The functionality of a therapeutic antibody candidate restored by a single mutation from proline to threonine in the variable region.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2023
Synthesis and Preclinical Fluorescence Imaging of Dually Functionalized Antibody Conjugates Targeting Endothelin Receptor-Positive Tumors.
Journal: Bioconjugate chemistry
Published: November 06, 2023
ImmunoPET imaging-based pharmacokinetic profiles of an antibody and its Fab targeting endothelin A receptors on glioblastoma stem cells in a preclinical orthotopic model.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 22, 2023
Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma.
Journal: HemaSphere
Published: December 22, 2022
Antibodies targeting human endothelin-1 receptors reveal different conformational states in cancer cells.
Journal: Physiological research
Published: June 28, 2018
Investigating the utility of minimized sample preparation and high-resolution mass spectrometry for quantification of monoclonal antibody drugs.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 15, 2018
Last Updated: 09/26/2026